1. Home
  2. OCUL vs NBTB Comparison

OCUL vs NBTB Comparison

Compare OCUL & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCUL
  • NBTB
  • Stock Information
  • Founded
  • OCUL 2006
  • NBTB 1856
  • Country
  • OCUL United States
  • NBTB United States
  • Employees
  • OCUL N/A
  • NBTB N/A
  • Industry
  • OCUL Biotechnology: Pharmaceutical Preparations
  • NBTB Major Banks
  • Sector
  • OCUL Health Care
  • NBTB Finance
  • Exchange
  • OCUL Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • OCUL 2.3B
  • NBTB 2.3B
  • IPO Year
  • OCUL 2014
  • NBTB N/A
  • Fundamental
  • Price
  • OCUL $11.26
  • NBTB $41.29
  • Analyst Decision
  • OCUL Strong Buy
  • NBTB Buy
  • Analyst Count
  • OCUL 9
  • NBTB 3
  • Target Price
  • OCUL $22.13
  • NBTB $52.33
  • AVG Volume (30 Days)
  • OCUL 3.2M
  • NBTB 188.4K
  • Earning Date
  • OCUL 11-13-2025
  • NBTB 10-27-2025
  • Dividend Yield
  • OCUL N/A
  • NBTB 3.59%
  • EPS Growth
  • OCUL N/A
  • NBTB 7.37
  • EPS
  • OCUL N/A
  • NBTB 2.77
  • Revenue
  • OCUL $56,664,000.00
  • NBTB $591,283,000.00
  • Revenue This Year
  • OCUL N/A
  • NBTB $26.94
  • Revenue Next Year
  • OCUL $18.87
  • NBTB $11.40
  • P/E Ratio
  • OCUL N/A
  • NBTB $14.88
  • Revenue Growth
  • OCUL N/A
  • NBTB 14.42
  • 52 Week Low
  • OCUL $5.79
  • NBTB $37.31
  • 52 Week High
  • OCUL $13.85
  • NBTB $52.44
  • Technical
  • Relative Strength Index (RSI)
  • OCUL 41.98
  • NBTB 38.96
  • Support Level
  • OCUL $10.85
  • NBTB $40.90
  • Resistance Level
  • OCUL $11.77
  • NBTB $42.92
  • Average True Range (ATR)
  • OCUL 0.72
  • NBTB 0.87
  • MACD
  • OCUL -0.16
  • NBTB -0.19
  • Stochastic Oscillator
  • OCUL 28.63
  • NBTB 8.91

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. Its business, predominantly conducted through NBT Bank, consists of providing commercial banking, retail banking, and wealth management services to customers in its market area, which includes upstate New York, northeastern Pennsylvania, southern New Hampshire, western Massachusetts, Vermont, southern Maine, and central and northwestern Connecticut. The company's reportable segments are Banking and Retirement Plan Administration. A majority of its revenue is generated from the Banking segment.

Share on Social Networks: